TCG Advisors’s West Pharmaceutical WST Stock Holding History

TCG Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26	Closed	-$3K	–	423
2019 Q2	$3K	Hold	26	–	–	﹤0.01%	402
2019 Q1	$3K	Buy	+26	New	+$2.7K	﹤0.01%	400

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

TCG Advisors's WST Position: Q3 2019 in Review

TCG Advisors sold out of West Pharmaceutical (WST) in Q3 2019, closing a stake of 26 shares — an estimated $3K sold.

TCG Advisors first reported a position in WST in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q2 2019. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

TCG Advisors reported no remaining West Pharmaceutical position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 26 West Pharmaceutical shares in Q3 2019, an estimated $3K.
TCG Advisors first reported a position in West Pharmaceutical in Q1 2019 and held it in 2 quarters.
TCG Advisors's West Pharmaceutical position peaked at $3K in Q2 2019.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.